Stem(STEM)

Search documents
Stem(STEM) - 2024 Q3 - Quarterly Report
2024-10-30 23:23
Financial Performance - Total revenue decreased from $133.7 million for the three months ended September 30, 2023, to $29.3 million for the same period in 2024, representing a decline of approximately 78%[94] - Net losses for the three months ended September 30, 2024, were $148.3 million, compared to net losses of $77.1 million for the same period in 2023, indicating an increase in losses of about 92%[94] - For the nine months ended September 30, 2024, total revenue was $88.8 million, down from $294.1 million for the same period in 2023, a decrease of approximately 70%[94] - The company incurred net losses of $802.9 million for the nine months ended September 30, 2024, compared to $102.7 million for the same period in 2023, reflecting a significant increase in losses[94] - Revenue for the three months ended September 30, 2024, was $29.3 million, a decrease from $133.7 million for the same period in 2023, representing a decline of approximately 78%[112] - Non-GAAP gross profit for the three months ended September 30, 2024, was $16.2 million, compared to $21.4 million in the same period of 2023, reflecting a decrease of about 24%[112] - Adjusted EBITDA for the three months ended September 30, 2024, was $(3.5) million, compared to $(0.9) million for the same period in 2023, indicating a worsening of performance[114] - GAAP gross profit for the three months ended September 30, 2024, was $6.2 million, compared to a loss of $20.3 million in the same period of 2023, reflecting a significant improvement[134] - Gross profit (loss) for the nine months ended September 30, 2024, was $(8.6) million, compared to $(7.4) million for the same period in 2023, reflecting a 16% increase in loss[147] Cash and Liquidity - As of September 30, 2024, the company had cash and cash equivalents of $75.4 million, down from $89.6 million as of June 30, 2024, and $105.4 million as of December 31, 2023[96] - As of September 30, 2024, cash and cash equivalents were $75.4 million, with net accounts receivable of $92.7 million[161] - The total financing obligation as of September 30, 2024, was $59.7 million, with $15.0 million classified as a current liability[163] - The company reported a net cash inflow of $72.5 million from changes in operating assets and liabilities for the nine months ended September 30, 2024[170] Revenue Trends and Constraints - Seasonal trends have historically led to most revenue being recognized in the third and fourth quarters, with these periods accounting for 65% of total revenue in the fiscal year ended December 31, 2023[102] - The company recorded a revenue constraint of $10.2 million in the nine months ended September 30, 2023, impacting overall revenue recognition[110] - The total dollar amount of indexed contracts related to lithium carbonate was approximately $52.0 million, with revenue recorded in Q1 2023 of approximately $42.0 million, net of a $10.2 million revenue constraint[110] - The company expects to receive final consideration of at least approximately $34.0 million from indexed contracts in the future[110] Operating Expenses - Total operating expenses increased by $102.7 million, or 214%, for the three months ended September 30, 2024, compared to the same period in 2023, driven by a significant impairment charge[134] - Operating expenses increased by $645.3 million, or 466%, for the nine months ended September 30, 2024, compared to the same period in 2023[147] - General and administrative expense increased by $5.3 million, or 24%, for the three months ended September 30, 2024, primarily due to a one-time contract cancellation payment of $10.0 million[140] - Research and development expenses decreased by $3.3 million, or 23%, for the three months ended September 30, 2024, compared to the same period in 2023[138] Market and Regulatory Environment - The company is assessing the impact of the U.S. Inflation Reduction Act of 2022 on its business and customer incentives, which may affect future revenue and cost structures[105] - The company faces increased competition from existing and new market entrants, which may adversely affect its market share and revenue generation capabilities[107] - Government regulations, including the IRA, significantly influence the pricing and deployment of the company's products and services, impacting overall business operations[108] Compliance and Notices - The company received a notice from the NYSE on August 28, 2024, for non-compliance with listing standards due to the average closing price of its shares falling below $1.00[98] Future Plans and Financing - Future expansion plans may include geographical expansion and joint ventures, but these are not required to achieve current business objectives[161] - The company issued $460.0 million aggregate principal amount of 2028 Convertible Notes, with net proceeds of approximately $445.7 million after expenses[164] - The company used approximately $99.8 million of the net proceeds from the 2030 Convertible Notes to purchase and cancel approximately $163.0 million of the 2028 Convertible Notes[167] - The 2030 Convertible Notes bear an interest rate of 4.25% per year, maturing on April 1, 2030[165] Backlog and Bookings - Bookings for the three months ended September 30, 2024, were $29.1 million, compared to $78.3 million in the same period of 2023[134] - Contracted backlog as of September 30, 2024, was $1,547.4 million, compared to $1,836.6 million as of September 30, 2023[134]
Stem, Inc. (STEM) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2024-10-30 23:01
Stem, Inc. (STEM) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -5%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.22, delivering a surprise of 4.35%. Over the last four quarters, the company has surpassed conse ...
Stem(STEM) - 2024 Q3 - Quarterly Results
2024-10-30 20:32
Revenue and Financial Performance - Revenue decreased 78% year-over-year to $29.3 million in 3Q24, down from $133.7 million in 3Q23, primarily due to reduced battery hardware sales and a $5.6 million adjustment from revised hardware contract valuations[1][5] - The company updated its full-year 2024 revenue guidance to $135-$155 million, down from the previous range of $200-$270 million, reflecting project delays and the new strategy implementation[14] - Total revenue for the nine months ended September 30, 2024, was $88.759 million, a significant decrease from $294.091 million in the same period in 2023[32] - Revenue for the three months ended September 30, 2024, was $29.3 million, compared to $133.7 million in the same period in 2023[38] - Revenue for the nine months ended September 30, 2024, was $88.8 million, compared to $294.1 million in the same period in 2023[38] Gross Margin and Profitability - GAAP gross margin improved to 21% in 3Q24, up from (15)% in 3Q23, driven by a higher mix of software and services revenue[1][6] - Non-GAAP gross margin reached a record 46% in 3Q24, up from 12% in 3Q23, reflecting strong growth in high-margin software and services revenue[1][7] - GAAP gross profit for the three months ended September 30, 2024, was $6.2 million, with a gross margin of 21%, compared to a loss of $20.3 million and a margin of -15% in 2023[38] - Non-GAAP gross profit for the three months ended September 30, 2024, was $16.2 million, with a gross margin of 46%, compared to $21.4 million and a margin of 12% in 2023[38] - GAAP gross profit for the nine months ended September 30, 2024, was a loss of $8.6 million, with a gross margin of -10%, compared to a loss of $7.4 million and a margin of -3% in 2023[38] - Non-GAAP gross profit for the nine months ended September 30, 2024, was $43.5 million, with a gross margin of 34%, compared to $52.9 million and a margin of 15% in 2023[38] - Gross loss for the nine months ended September 30, 2024, was $8.620 million, compared to a gross loss of $7.426 million in the same period in 2023[32] Net Loss and Impairments - Net loss widened to $148.3 million in 3Q24, compared to $77.1 million in 3Q23, primarily due to a $104.1 million bad debt expense related to impaired receivables[1][8] - Net loss for the nine months ended September 30, 2024, was $802.877 million, compared to a net loss of $102.728 million in the same period in 2023[32] - Net loss for the nine months ended September 30, 2024, was $802.9 million, compared to $102.7 million in the same period in 2023[34] - Impairment of goodwill for the nine months ended September 30, 2024, was $547.152 million[32] - Impairment of goodwill for the nine months ended September 30, 2024, was $547.2 million[34] - A bad debt expense of $104.1 million was recorded in Q3 2024 due to impairment of accounts receivable related to customer contracts with parent company guarantees[16][26] Cash Flow and Liquidity - Cash and cash equivalents decreased to $75.364 million as of September 30, 2024, from $105.375 million as of December 31, 2023[30] - Net cash used in operating activities for the nine months ended September 30, 2024, was $21.9 million, compared to $205.2 million in the same period in 2023[34] - Cash, cash equivalents, and restricted cash at the end of September 30, 2024, were $77.2 million, compared to $98.2 million at the end of September 30, 2023[34] - Proceeds from maturities of available-for-sale investments for the nine months ended September 30, 2024, were $8.3 million, compared to $119.7 million in the same period in 2023[34] - Repayment of financing obligations for the nine months ended September 30, 2024, was $7.0 million, compared to $7.8 million in the same period in 2023[34] Assets and Liabilities - Total current assets decreased to $227.530 million as of September 30, 2024, from $472.965 million as of December 31, 2023[30] - Total liabilities decreased to $881.390 million as of September 30, 2024, from $930.296 million as of December 31, 2023[30] Bookings and Backlog - Contracted backlog decreased 2% sequentially to $1.55 billion in 3Q24, driven by low bookings and backlog conversion to revenue[9] - Bookings dropped to $29.1 million in 3Q24, down from $676.4 million in 3Q23, reflecting the strategic shift towards higher-margin software and services[10] - Contracted Backlog represents the total value of bookings in dollars as of a specific date, increasing with new contracts and decreasing as systems are delivered and recognized as revenue[41] Contracted Assets and Recurring Revenue - Contracted storage AUM increased 3% sequentially to 6.0 GWh in 3Q24, while solar monitoring AUM rose 6% to 28.5 GW[10] - CARR grew 2% sequentially to $92.3 million in 3Q24, up from $90.1 million in 2Q24[11] - Contracted Assets Under Management (AUM) includes the total GWh of storage systems in operation or under contract[41] - Contracted Annual Recurring Revenue (CARR) is the annual run rate for all executed software services contracts, including those for systems not yet commissioned or operating[41] Strategic Shifts and Leadership - The company appointed Albert Hofeldt as Chief Technology Officer to lead enhanced AI-enabled software and edge device capabilities as part of the new software and services-centric strategy[13] - The company has not issued new hardware value guarantees since June 2023 and does not intend to issue any in the future[16] Non-GAAP Metrics - Adjusted EBITDA and non-GAAP gross profit are used for financial and operational decision-making, excluding certain expenses like stock-based compensation and non-cash charges[19][20] - Non-GAAP gross margin is defined as non-GAAP gross profit as a percentage of revenue[23] - Adjusted EBITDA for the nine months ended September 30, 2024, was $(27.0) million, compared to $(24.1) million in the same period in 2023[37] Market Conditions and Risks - The company recorded a net revenue reduction of $37.4 million in hardware revenue for Q3 2023, $38.7 million for Q1 2024, and $5.6 million for Q3 2024 due to market conditions and revised asset valuations[16] - The company faces risks from macroeconomic factors, including inflation, interest rates, geopolitical tensions, and potential economic slowdowns[17] - Forward-looking statements include expectations regarding financial targets, business strategy, and the impact of macroeconomic and geopolitical factors[28] Lithium Carbonate Contracts - The company recorded $42 million in revenue for Q1 2023, net of a $10 million revenue constraint, related to indexed contracts tied to lithium carbonate prices[24] - The total dollar amount of indexed purchase orders for lithium carbonate-related contracts is approximately $52 million[24] - The company expects to receive at least $34 million in final consideration from indexed purchase orders[24] Operating Expenses and Share Metrics - Total operating expenses for the nine months ended September 30, 2024, were $783.693 million, compared to $138.367 million in the same period in 2023[32] - Weighted-average shares used in computing net loss per share increased to 160,997,019 for the nine months ended September 30, 2024, from 155,474,725 in the same period in 2023[32] - Stock-based compensation for the nine months ended September 30, 2024, was $21.7 million, compared to $28.3 million in the same period in 2023[34] - Depreciation and amortization expense for the nine months ended September 30, 2024, was $33.2 million, compared to $33.6 million in the same period in 2023[34] - Change in fair value of derivative liability for the nine months ended September 30, 2024, was $(1.5) million, compared to $7.7 million in the same period in 2023[34] Customer Contracts and Installations - Customer contracts are typically executed 6-24 months ahead of installation, with bookings including hardware and services revenue[40]
SkinSpirit joins Allergan Aesthetics in Supporting Girls Inc. and Empowering the New Generation of Women in STEM
Prnewswire· 2024-10-29 12:00
SkinSpirit will make a kick-off donation and offer clients the ability to donate directly to Girls Inc. from November 1 – 15thIRVINE, Calif., Oct. 29, 2024 /PRNewswire/ -- In its sixth year of partnership with Girls Inc., Allergan Aesthetics, an AbbVie company, will be joined by SkinSpirit, a premier destination for medical aesthetics and skincare, in their efforts to inspire girls to be strong, smart and bold and explore career paths in STEM.In its first year of participation, SkinSpirit will kick off the ...
Stem, Inc. (STEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
ZACKS· 2024-10-23 15:07
Stem, Inc. (STEM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 30 ...
Stem, Inc. (STEM) Reports Q2 Loss, Lags Revenue Estimates
ZACKS· 2024-08-06 23:15
Stem, Inc. (STEM) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.56 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.35%. A quarter ago, it was expected that this company would post a loss of $0.20 per share when it actually produced a loss of $0.46, delivering a surprise of -130%. Over the last four quarters, the company has surpassed con ...
Stem, Inc. (STEM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
ZACKS· 2024-07-25 15:07
Wall Street expects a year-over-year increase in earnings on lower revenues when Stem, Inc. (STEM) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move ...
Stem(STEM) - 2024 Q1 - Earnings Call Transcript
2024-05-03 01:06
Start Time: 17:00 January 1, 0000 6:02 PM ET Stem, Inc. (NYSE:STEM) Q1 2024 Earnings Conference Call May 02, 2024, 17:00 PM ET Company Participants John Carrington - CEO Bill Bush - CFO Prakesh Patel - Chief Strategy Officer Ted Durbin - Head of IR Conference Call Participants James West - Evercore ISI Jon Windham - UBS Andrew Percoco - Morgan Stanley Thomas Boyes - TD Cowen Justin Clare - ROTH NKM Ryan Lee - Goldman Sachs Joe Osha - Guggenheim Partners Kashy Harrison - Piper Sandler Operator Greetings, and ...
Stem(STEM) - 2024 Q1 - Quarterly Report
2024-05-02 23:18
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ————————————————— 100 California St., 14th Fl., San Francisco, California 94111 FORM 10-Q ————————————————— ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ STEM, INC. (Exact name of registrant as specified ...
Stem(STEM) - 2024 Q1 - Quarterly Results
2024-05-02 20:23
Exhibit 99 Stem Announces First Quarter 2024 Results Substantial increase of +42% CARR-to-ARR conversion since January 2024 Introducing Next Generation Asset Performance Management Software Suite Reaffirming Full Year 2024 Operating Cash Flow, Adjusted EBITDA, Gross Margin and Bookings Guidance First Quarter 2024 Financial and Operating Highlights Financial Highlights 1 Operating Highlights SAN FRANCISCO – May 2, 2024 – Stem, Inc. ("Stem" "we" or the "Company") (NYSE: STEM), a global leader in artificial in ...